Residual Vascular Risk in T2DM: The Next Frontier
None
I tiakina i:
| Ngā kaituhi matua: | Hermans, Michel P., Ahn, Sylvie A., Rousseau, Michel F. |
|---|---|
| Hōputu: | Tāhiko Wāhanga pukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
IntechOpen
2011
|
| Ngā marau: | |
| Urunga tuihono: | https://www.intechopen.com/chapters/18536 |
| Tags: |
Tāpirihia he Tūtohu
No Tags, Be the first to tag this record!
|
Ngā tūemi rite
-
Functional Context Network of T2DM
mā: Thormann, Anja, me ētahi atu.
I whakaputaina: (2011) -
Pharmacogenetics for T2DM and Anti-Diabetic Drugs
mā: Huang, Qiong, me ētahi atu.
I whakaputaina: (2011) -
Myotonic Dystrophy Type 1 (DM1): From the Genetics to Molecular Mechanisms
mā: Magaña, Jonathan J., me ētahi atu.
I whakaputaina: (2012) -
Inherited Thrombophilia and the Risk of Vascular Events
mā: Novaković, Ivana, me ētahi atu.
I whakaputaina: (2011) -
Interferon Lambda: The Next Frontier in Antiviral Therapy?
mā: Sofia Chronopoulou, me ētahi atu.
I whakaputaina: (2025-05-01)


